Remove Clinic Remove Diagnostic Remove MRI
article thumbnail

PI-RADS optimizes MRI-based diagnostics for prostate cancer detection

AuntMinnie

It's better to take Prostate Imaging-Reporting and Data System (PI-RADS) upgrading rules into account when it comes to deciding whether a patient with clinically significant prostate cancer needs a biopsy, researchers have reported. "[Our] The study results were published February 14 in the American Journal of Roentgenology.

article thumbnail

Halo Precision Diagnostics Collaborating with Bayer to Advance Contrast-Enhanced MRI

Imaging Technology

milla1cf Tue, 10/17/2023 - 12:49 October 17, 2023 — Halo Precision Diagnostics , a leader in early disease detection using precision diagnostics, today announced a collaboration with Bayer , a global leader in radiology, to join QUANTI, Bayer’s Phase III clinical development program for gadoquatrane.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AI model comparable to radiologists for finding prostate cancer on MRI

AuntMinnie

A deep-learning model performs comparably to an abdominal radiologist when it comes to finding clinically significant prostate cancer on MRI, researchers have reported. It's not that] we can use this model as a standalone diagnostic tool," he said, "[but] the model's prediction can be used as an adjunct in our decision-making process."

article thumbnail

Predicting Clinically Significant Prostate Cancer: Can a Prostate MRI Point-Based Model Have an Impact?

Diagnostic Imaging

A point-based model that incorporates prostate MRI findings offered a sensitivity rate of 89.5 percent for detecting clinically significant prostate cancer and could prevent over 20 percent of biopsies, according to new research.

Clinic 94
article thumbnail

PET/MRI superior to PET/CT in cancer patients

AuntMinnie

FDG-PET/MRI is comparable or superior in diagnostic performance to FDG-PET/CT across a range of cancers and endpoints, according to a review of head-to-head studies published July 17 in the American Journal of Roentgenology. PET/MRI showed a staging accuracy in breast cancer of 98% versus 74.5% versus 69.2%. versus 69.2%.

MRI 111
article thumbnail

FDG PET/CT vs. FDG PET/MRI in Cancer Patients: Systematic Review and Meta-Analysis

Imaging Technology

mtaschetta-millane Wed, 07/31/2024 - 07:30 July 31, 2024 — In a head-to-head comparison with FDG PET/CT , FDG PET/MRI demonstrated comparable or superior diagnostic performance across a range of cancers and endpoints, according to the American Journal of Roentgenology ( AJR ). Poon et al.

MRI 105
article thumbnail

Exploring Ferumoxytol: A Frontier in MRI Contrast Agents

Imaging Technology

milla1cf Fri, 03/29/2024 - 08:01 March 29, 2024 — Magnetic resonance imaging ( MRI ) is a cornerstone in the landscape of medical diagnostics, celebrated for its non-ionizing and non-invasive nature. Since its clinical introduction in 2009, Ferumoxytol-enhanced MRI (FE-MRI) has significantly reshaped CE-MRI practices.

MRI 104